HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

decamethonium (decamethonium bromide)

RN given refers to parent cpd
Also Known As:
decamethonium bromide; (DM)Br2; decamethonium dibromide; decamethonium dichloride; decamethonium dihydroxide; decamethonium diiodide; decamethonium dipricrate; decamethonium iodide; decamethylenebis(trimethylammonium)bromide
Networked: 48 relevant articles (0 outcomes, 1 trials/studies) for this Drug, Comments

Drug Context: Research Results

Experts

1. Pitsillides, Andrew A: 1 article (04/2006)
2. Patel, Ketan: 1 article (04/2004)
3. Otto, William R: 1 article (04/2004)
4. McKinnell, Iain W: 1 article (04/2004)
5. Macharia, Raymond: 1 article (04/2004)
6. Christ, Bodo: 1 article (04/2004)
7. Cavrini, Vanni: 1 article (02/2003)
8. Bertucci, Carlo: 1 article (02/2003)
9. Bartolini, Manuela: 1 article (02/2003)
10. Andrisano, Vincenza: 1 article (02/2003)

Related Diseases

1. Neuromuscular Diseases (Neuromuscular Disease)
2. Paralysis (Palsy)
3. Myasthenia Gravis
4. Seizures (Seizure)
5. Ganglion Cysts (Ganglion)
01/01/1980 - "In order to examine the applicability of this method, we chose the excitatory type of acetylcholine-induced responses of the ganglion cells in Aplysia, and analyzed the mode of inhibition by decamethonium (Deca) and tetraethylammonium (TEA). "
11/01/1986 - "The blocking properties of tubocurarine, decamethonium, hexamethonium and trimetaphan on nicotinic agonists applied by repetitive ionophoretic pulses were examined in rat submandibular ganglion cells using a two-microelectrode voltage-clamp technique at 30 degrees C. "
03/01/1970 - "1. When the movement of the nictitating membrane is recorded in the usual way, pulled out under load in cat, dog, or rabbit, end-plate-depolarizing drugs such as succinylcholine, decamethonium, nicotine, and 2268F, cause a retraction.2. This movement is due to activation of orbital striated muscle, as evidenced by the resistance of the movement to ganglion block or excision of the superior cervical ganglion and to administration of phentolamine or atropine, and by its great sensitivity to dimethyltubocurarine.3. End-plate-depolarizing drugs produce contractions of the superior and inferior oblique and of the recti muscles strong enough to account for the movements of the nictitating membrane, provided the known fascial connexions of the orbit allow transmission of a fraction of the extraocular muscle movement to the membrane.4. In post mortem specimens with the front of the orbit undisturbed, retraction of the central end of any of the ocular muscles produces movement of the nictitating membrane; the movement was greatest with the superior oblique and medial rectus. "
09/01/1969 - "1. The ganglion blocking agents, chlorisondamine, pentamethonium, mecamylamine, decamethonium and hexamethonium all block nicotine extensor convulsions when administered intraventricularly in mice. "
Order ALL the reference details at left...

Related Drugs and Biologics

1. Succinylcholine (Suxamethonium Chloride)
2. Potassium
3. Neuromuscular Depolarizing Agents
4. Tubocurarine (Tubocurarine Chloride)
5. Acetylcholine (Acetylcholine Chloride)
6. Nicotine
7. Gallamine Triethiodide (Gallamine)
8. Curare
9. Hexamethonium (Hexamethonium Bromide)
10. Tacrine (Cognex)

Related Therapies and Procedures

1. Positive-Pressure Respiration (PEEP)
2. Microelectrodes
3. Intravenous Injections
4. Injections

blog comments powered by Disqus
TREATMENT OPTIONS
for Neuromuscular Diseases,
Ranking and Evidence
*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.
  • Free Updates for 1 Year
  • All 18 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Evidence References
  • Sample PDF Report on Psoriasis >>
Price:$8.50 USD & Delivery via PDF download
updates for 1 year
Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:
Price:$45.00 USD access via web interface
1 year subscription
Request Bulk Institution License Details >>